Bridge to Life Ltd. Announces Early Results from its Pivotal Bridge to HOPE Liver Clinical Trial
Bridge to Life, Ltd. announced early results from its multicenter, randomized, controlled Bridge to HOPE Liver Clinical Trial.
Archives
Tag Archives for: "2022"
Latest Posts
UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System
August 27, 2026
DULUTH, GA, & LONDON, UK - August 27, 2026 - Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of […]
Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond
August 12, 2026
Financing will further accelerate the already successful early commercial rollout of VitaSmart™ HOPE System Company also advancing an active organ viability assessment tool designed to raise industry standards with a […]
New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants
June 23, 2026
Studies in human uterus and small intestine transplants, including head-to-head comparison with normothermic oxygenated perfusion, presented at 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston Duluth, GA […]
US Operations:
3300 Breckinridge Blvd. Suite 200 | Duluth, GA 30096 USA
© 2026 Bridge to Life™ Ltd. All rights reserved.